2nd Lab Asset and Facility Management in Pharma Europe

The last 12 months have highlighted key milestones in European biopharma investment– from GSK injecting €1 million into a 15-building biotech campus in Stevenage, to AstraZeneca investing £1 billion into a new R AND D and Corporate HQ. As the pressure to expand and continue pipeline progression within a scattered and distributed market, there has never been a better time to know how to navigate unknown waters.

Emulating the 2023 success, the Lab Asset and Facility Management in Pharma Europe returns for the second year running. This expert-led summit is solely dedicated to imparting expert knowledge with the goal of expediting operational excellence in laboratories across Europe.

Join 80+ senior lab, R AND D operations, lab workplace strategy, lab equipment, and asset leaders from the likes of AstraZeneca, Novartis, and Abcam to:
- Discuss asset optimisation and maintenance strategies to reduce equipment downtime
- Expedite lab capabilities and overcome workspace constraints that will ensure a user-centric lab
- Drive green practices – keeping sustainability at the forefront of decisions and exploring energy efficient strategies
- Embrace the power of digitisation holistically within lab operations, and learn how to navigate your data lake by overcoming the challenge of various data outputs
- Build long-lasting, dependable contract relationships to maximise value and improve equipment service capabilities
- Explore strategies for incorporating and enhancing GxP to ensure an efficient R AND D scale up


URLs:
Website: https://go.evvnt.com/2048864-0?pid=10018
Tickets: https://go.evvnt.com/2048864-2?pid=10018
Brochure: https://go.evvnt.com/2048864-3?pid=10018

Prices:
Conference Only - Hospitals, Not-for-Profit and Start-Up Pricing: EUR 2449.00,
Conference + 1 Workshop - Hospitals, Not-for-Profit and Start-Up Pricing: EUR 2715.00,
Conference + 2 Workshops - Hospitals, Not-for-Profit and Start-Up Pricing: EUR 2981.00,
Conference Only - Drug Developers, CDMO, CRO and Diagnostics Pricing: EUR 2849.00,
Conference + 1 Workshop - Drug Developers, CDMO, CRO and Diagnostics Pricing: EUR 3182.00,
Conference + 2 Workshops - Drug Developers, CDMO, CRO and Diagnostics Pricing: EUR 3515.00,
Conference Only - Solution Providers Pricing: EUR 3449.00,
Conference + 1 Workshop - Solution Providers Pricing: EUR 4248.00,
Conference + 2 Workshops - Solution Providers Pricing: EUR 5047.00

Speakers: Bill Jun, Product Manager – Research and Development, Roche, Francesco Nicolini, Senior Operations Manager, Synthace, Holly Duckworth, BIS DDQ Operations Manager, Iwan de Koning, Regional Lab Services Leader EMEA, Janssen Pharmaceutical, Jeremy Holmes, Head of Engineering Facilities and Science Services, The Francis Crick Institute, Ke Li, Product Manager Lab Automation, Roche, Koji Urata, Product Lifecycle Engineering Manager - Bioware, ONI, Lisbhit England, Global Procurement Category Manager, Novartis, Ludivine Bellot, Former Head of Infrastructure and Lab Equipment Delivery, Senior Director, GSK, Martin Frohock, Head of Workplace – EMEA, Abcam, Richard Snell, Director, Global Scientific Services, GSK, Shahzeb Choudhry, Laboratory Manager, Procella Therapeutics, Shaun Rhodes Director, Supplier Relationship, AstraZeneca, Stuart Wonfor, Senior End to End Service Manager, AstraZeneca, Timmy Carey, Director Global EHS AND S Environmental Sustainability, BioMarin, Torsten Offergeld, Head of Laboratory Strategy, Roche Diagnostics